Eloxx Pharmaceuticals, Inc.

OTCPK:ELOX Stock Report

Market Cap: US$3.0

Eloxx Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of ELOX?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders211,9956.42%
Institutions249,4517.56%
VC/PE Firms366,22511.1%
General Public2,472,85774.9%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 5%.


Top Shareholders

Top 10 shareholders own 25.08% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
11.1%
Pontifax Venture Capital
366,225US$0.30%no data
5.15%
Sumit Aggarwal
169,930US$0.23,350%no data
3.79%
Advent Life Sciences LLP
124,972US$0.10%no data
3.77%
Gurnet Point Capital Limited
124,417US$0.10%100.0%
0.39%
Alan Walts
12,942US$0.011,270%no data
0.36%
Steven Rubin
12,000US$0.010%no data
0.36%
Lindsay Androski
12,000US$0.010%no data
0.12%
Vijay Modur
3,873US$0.0040%no data
0.038%
Daniel Geffken
1,250US$0.0010%no data
0.0019%
Old Point Trust & Financial Services, N.A.
62US$0.000060%no data